Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy - Giannitsis, E; Hamm, CW; Böhm, M (Eur Heart J, 2021)
et al.